Impairment of HLA Class I-Restricted Associated with Antigen Processing Results in Protein BNLF2a to the Transporter Specific Targeting of the EBV Lytic Phase
暂无分享,去创建一个
M. Ressing | N. Croft | A. Rickinson | E. Wiertz | D. Horst | M. Garstka | A. Hislop | Élisabeth | D. V. Leeuwen | Kremmer
[1] R. Tampé,et al. The Varicellovirus UL49.5 Protein Blocks the Transporter Associated with Antigen Processing (TAP) by Inhibiting Essential Conformational Transitions in the 6+6 Transmembrane TAP Core Complex1 , 2008, The Journal of Immunology.
[2] R. Tampé,et al. Signaling of a Varicelloviral Factor across the Endoplasmic Reticulum Membrane Induces Destruction of the Peptide-loading Complex and Immune Evasion* , 2008, Journal of Biological Chemistry.
[3] R. Tampé,et al. Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP , 2008, PLoS pathogens.
[4] R. Tampé,et al. The Varicellovirus UL 49 . 5 Protein Blocks the Transporter Associated with Antigen Processing ( TAP ) by Inhibiting Essential Conformational Transitions in the 6 6 Transmembrane TAP Core Complex 1 , 2008 .
[5] M. Ressing,et al. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. , 2007, International immunology.
[6] M. Ressing,et al. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.
[7] M. Preuss,et al. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin , 2007, Nature Immunology.
[8] P. Cresswell,et al. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer , 2007, Nature Immunology.
[9] K. Knoops,et al. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. , 2007, The Journal of general virology.
[10] K. Bieńkowska-Szewczyk,et al. Bovine Herpesvirus 1 UL49.5 Protein Inhibits the Transporter Associated with Antigen Processing despite Complex Formation with Glycoprotein M , 2006, Journal of Virology.
[11] F. Momburg,et al. Physical and Functional Interactions of the Cytomegalovirus US6 Glycoprotein with the Transporter Associated with Antigen Processing* , 2006, Journal of Biological Chemistry.
[12] E. Kieff,et al. Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication , 2006, Journal of Virology.
[13] P. Lehner,et al. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases , 2005, Immunological reviews.
[14] H. Ploegh,et al. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond , 2005, Immunological reviews.
[15] M. Ressing,et al. Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection1 , 2005, The Journal of Immunology.
[16] R. Tampé,et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Lehner,et al. Viral degradation of the MHC class I peptide loading complex. , 2004, Immunity.
[18] K. Früh,et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.
[19] P. Cresswell,et al. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids , 2004, Immunogenetics.
[20] H. Ploegh,et al. The ER‐Lumenal Domain of the HHV‐7 Immunoevasin U21 Directs Class I MHC Molecules to Lysosomes , 2003, Traffic.
[21] R. Øvstebø,et al. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. , 2003, Clinical chemistry.
[22] H. Virgin,et al. Virus subversion of the MHC class I peptide-loading complex. , 2003, Immunity.
[23] J. Yewdell,et al. Viral interference with antigen presentation , 2002, Nature Immunology.
[24] E. Wiertz,et al. Viral immune evasion: a masterpiece of evolution , 2002, Immunogenetics.
[25] L. Lybarger,et al. Physical Association of the K3 Protein of Gamma-2 Herpesvirus 68 with Major Histocompatibility Complex Class I Molecules with Impaired Peptide and β2-Microglobulin Assembly , 2002, Journal of Virology.
[26] H. Heslop,et al. Treatment of Epstein-Barr virus-associated malignancies with specific T cells. , 2002, Advances in cancer research.
[27] R. Tampé,et al. Molecular Mechanism and Structural Aspects of Transporter Associated with Antigen Processing Inhibition by the Cytomegalovirus Protein US6* , 2001, The Journal of Biological Chemistry.
[28] H. Ploegh,et al. A Human Herpesvirus 7 Glycoprotein, U21, Diverts Major Histocompatibility Complex Class I Molecules to Lysosomes , 2001, Journal of Virology.
[29] R. Tampé,et al. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. , 2001, Cancer research.
[30] P. Stevenson,et al. MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.
[31] P. Cresswell,et al. Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] P. Lehner,et al. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP , 2001, The EMBO journal.
[33] P. Lehner,et al. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Ganem,et al. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. Hammerschmidt,et al. The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators , 2000, The EMBO journal.
[36] Jae U. Jung,et al. Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.
[37] J. Neefjes,et al. The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.
[38] P. A. Peterson,et al. Human Cytomegalovirus Immediate Early Glycoprotein US3 Retains MHC Class I Molecules by Transient Association , 2000, Traffic.
[39] Structure of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy. , 1999, Biochemistry.
[40] A. Plebani,et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. , 1999, The Journal of clinical investigation.
[41] U. Koszinowski,et al. A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.
[42] J. C. Cross,et al. Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alternative splicing of the tapasin gene , 1998, European journal of immunology.
[43] M. Androlewicz,et al. Herpes Simplex Virus Inhibitor ICP47 Destabilizes the Transporter Associated with Antigen Processing (TAP) Heterodimer* , 1998, The Journal of Biological Chemistry.
[44] P. Cresswell,et al. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. , 1998, Immunity.
[45] J. Trowsdale,et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.
[46] R. Tampé,et al. The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing. , 1997, Journal of molecular biology.
[47] P. Cresswell,et al. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. F. Cook,et al. The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues , 1997, The Journal of experimental medicine.
[49] P. A. Peterson,et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.
[50] U. Koszinowski,et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.
[51] R. Tampé,et al. Structure of the viral TAP-inhibitor ICP47 induced by membrane association. , 1997, Biochemistry.
[52] H. Ploegh,et al. Viruses use stealth technology to escape from the host immune system. , 1997, Molecular medicine today.
[53] U. Koszinowski,et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.
[54] T. Rapoport,et al. Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.
[55] P. Cresswell,et al. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.
[56] D. Andrews,et al. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. , 1996, The EMBO journal.
[57] P. A. Peterson,et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. , 1996, The EMBO journal.
[58] M. Bogyo,et al. The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.
[59] J. Yewdell,et al. Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses (*) , 1995, The Journal of Biological Chemistry.
[60] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[61] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[62] J. Salamero,et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.
[63] D. Andrews,et al. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes , 1994, Cell.
[64] J. Slot,et al. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.
[65] M. Brenner,et al. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[66] R. Demars,et al. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.
[67] H. Ploegh,et al. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.
[68] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.